A radiosotope-chitosan complex for treatment of prostate cancer
    1.
    发明申请
    A radiosotope-chitosan complex for treatment of prostate cancer 审中-公开
    一种用于治疗前列腺癌的放射性脱氧壳聚糖复合物

    公开(公告)号:US20060286032A1

    公开(公告)日:2006-12-21

    申请号:US10570295

    申请日:2004-09-08

    IPC分类号: A61K51/00 C08B37/08

    CPC分类号: A61K51/06 A61K51/1282

    摘要: Disclosed is a composition for treating prostate cancer. The composition for treating prostate cancer comprises as an effective ingredient a radioisotope-chitosan complex that includes a therapeutic radioisotope emitting beta radiation and chitosan. Also, the present invention discloses a kit for preparing the composition. When directly administered to a prostate cancer tissue, the radioisotope- chitosan complex is deposited in the applied target site while not leaking from the applied target site, and strongly inhibits the growth of prostate cancer cells while minimizing the side effects of conventional therapies, including urinary incontinence, urethral stricture and rectal bleeding. In addition, the radioisotope-chitosan complex may be used as an effective therapeutic agent for hormone-independent prostate cancer that is resistant to hormone therapy.

    摘要翻译: 公开了用于治疗前列腺癌的组合物。 用于治疗前列腺癌的组合物包括放射性同位素 - 壳聚糖复合物作为有效成分,其包括发射β辐射和壳聚糖的治疗性放射性同位素。 此外,本发明公开了一种用于制备组合物的试剂盒。 当直接施用于前列腺癌组织时,放射性同位素 - 壳聚糖复合物沉积在施用的靶位点,而不会从施用的靶位点泄漏,并强烈地抑制前列腺癌细胞的生长,同时最小化常规治疗的副作用,包括尿 尿失禁,尿道狭窄和直肠出血。 此外,放射性同位素 - 壳聚糖复合物可用作对激素治疗具有抗性的激素非依赖性前列腺癌的有效治疗剂。